nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Benazepril—Enalapril—coronary artery disease	0.154	0.282	CrCrCtD
Solifenacin—Benazepril—Trandolapril—coronary artery disease	0.154	0.282	CrCrCtD
Solifenacin—Benazepril—Lisinopril—coronary artery disease	0.12	0.221	CrCrCtD
Solifenacin—Benazepril—Ramipril—coronary artery disease	0.117	0.214	CrCrCtD
Solifenacin—CYP3A4—Ticagrelor—coronary artery disease	0.0265	0.146	CbGbCtD
Solifenacin—CYP3A4—Fenofibrate—coronary artery disease	0.0236	0.131	CbGbCtD
Solifenacin—CYP3A4—Gemfibrozil—coronary artery disease	0.0189	0.104	CbGbCtD
Solifenacin—CYP3A4—Clopidogrel—coronary artery disease	0.0164	0.0905	CbGbCtD
Solifenacin—CYP3A4—Eplerenone—coronary artery disease	0.0152	0.0841	CbGbCtD
Solifenacin—CYP3A4—Enalapril—coronary artery disease	0.0135	0.075	CbGbCtD
Solifenacin—CYP3A4—Rosuvastatin—coronary artery disease	0.0105	0.0583	CbGbCtD
Solifenacin—CYP3A4—Ezetimibe—coronary artery disease	0.0105	0.0583	CbGbCtD
Solifenacin—CYP3A4—Simvastatin—coronary artery disease	0.0098	0.0542	CbGbCtD
Solifenacin—CYP3A4—Pravastatin—coronary artery disease	0.00959	0.053	CbGbCtD
Solifenacin—CYP3A4—Lovastatin—coronary artery disease	0.00959	0.053	CbGbCtD
Solifenacin—CYP3A4—Atorvastatin—coronary artery disease	0.00873	0.0483	CbGbCtD
Solifenacin—CYP3A4—Losartan—coronary artery disease	0.00799	0.0442	CbGbCtD
Solifenacin—Benazepril—MTHFR—coronary artery disease	0.000829	0.551	CrCbGaD
Solifenacin—Benazepril—ACE—coronary artery disease	0.000676	0.449	CrCbGaD
Solifenacin—Dizziness—Lovastatin—coronary artery disease	0.000101	0.000555	CcSEcCtD
Solifenacin—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000101	0.000554	CcSEcCtD
Solifenacin—Somnolence—Furosemide—coronary artery disease	0.0001	0.000553	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Perindopril—coronary artery disease	0.0001	0.000552	CcSEcCtD
Solifenacin—Fatigue—Perindopril—coronary artery disease	0.0001	0.000551	CcSEcCtD
Solifenacin—Cough—Ramipril—coronary artery disease	9.99e-05	0.00055	CcSEcCtD
Solifenacin—Urticaria—Trandolapril—coronary artery disease	9.95e-05	0.000548	CcSEcCtD
Solifenacin—Constipation—Perindopril—coronary artery disease	9.93e-05	0.000547	CcSEcCtD
Solifenacin—Vomiting—Fenofibrate—coronary artery disease	9.93e-05	0.000547	CcSEcCtD
Solifenacin—Hypersensitivity—Valsartan—coronary artery disease	9.92e-05	0.000546	CcSEcCtD
Solifenacin—Urticaria—Enalapril—coronary artery disease	9.91e-05	0.000545	CcSEcCtD
Solifenacin—Abdominal pain—Trandolapril—coronary artery disease	9.9e-05	0.000545	CcSEcCtD
Solifenacin—Dizziness—Ezetimibe—coronary artery disease	9.89e-05	0.000545	CcSEcCtD
Solifenacin—Palpitations—Timolol—coronary artery disease	9.89e-05	0.000544	CcSEcCtD
Solifenacin—Abdominal pain—Enalapril—coronary artery disease	9.86e-05	0.000543	CcSEcCtD
Solifenacin—Feeling abnormal—Captopril—coronary artery disease	9.86e-05	0.000543	CcSEcCtD
Solifenacin—Rash—Fenofibrate—coronary artery disease	9.84e-05	0.000542	CcSEcCtD
Solifenacin—Dermatitis—Fenofibrate—coronary artery disease	9.84e-05	0.000542	CcSEcCtD
Solifenacin—Decreased appetite—Furosemide—coronary artery disease	9.81e-05	0.00054	CcSEcCtD
Solifenacin—Headache—Fenofibrate—coronary artery disease	9.78e-05	0.000539	CcSEcCtD
Solifenacin—Vision blurred—Lisinopril—coronary artery disease	9.78e-05	0.000539	CcSEcCtD
Solifenacin—Gastrointestinal pain—Captopril—coronary artery disease	9.78e-05	0.000539	CcSEcCtD
Solifenacin—Urticaria—Telmisartan—coronary artery disease	9.77e-05	0.000538	CcSEcCtD
Solifenacin—Cough—Timolol—coronary artery disease	9.76e-05	0.000538	CcSEcCtD
Solifenacin—Vomiting—Clopidogrel—coronary artery disease	9.76e-05	0.000537	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Furosemide—coronary artery disease	9.75e-05	0.000537	CcSEcCtD
Solifenacin—Fatigue—Furosemide—coronary artery disease	9.73e-05	0.000536	CcSEcCtD
Solifenacin—Abdominal pain—Telmisartan—coronary artery disease	9.72e-05	0.000535	CcSEcCtD
Solifenacin—Vomiting—Lovastatin—coronary artery disease	9.69e-05	0.000534	CcSEcCtD
Solifenacin—Somnolence—Losartan—coronary artery disease	9.68e-05	0.000533	CcSEcCtD
Solifenacin—Dizziness—Eplerenone—coronary artery disease	9.68e-05	0.000533	CcSEcCtD
Solifenacin—Rash—Clopidogrel—coronary artery disease	9.68e-05	0.000533	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	9.67e-05	0.000533	CcSEcCtD
Solifenacin—Dermatitis—Clopidogrel—coronary artery disease	9.67e-05	0.000532	CcSEcCtD
Solifenacin—Asthenia—Valsartan—coronary artery disease	9.66e-05	0.000532	CcSEcCtD
Solifenacin—Hypertension—Timolol—coronary artery disease	9.66e-05	0.000532	CcSEcCtD
Solifenacin—Constipation—Furosemide—coronary artery disease	9.65e-05	0.000532	CcSEcCtD
Solifenacin—Hypersensitivity—Niacin—coronary artery disease	9.65e-05	0.000531	CcSEcCtD
Solifenacin—Asthenia—Olmesartan—coronary artery disease	9.62e-05	0.000529	CcSEcCtD
Solifenacin—Headache—Clopidogrel—coronary artery disease	9.61e-05	0.000529	CcSEcCtD
Solifenacin—Rash—Lovastatin—coronary artery disease	9.61e-05	0.000529	CcSEcCtD
Solifenacin—Dermatitis—Lovastatin—coronary artery disease	9.6e-05	0.000529	CcSEcCtD
Solifenacin—Dyspepsia—Losartan—coronary artery disease	9.59e-05	0.000528	CcSEcCtD
Solifenacin—Feeling abnormal—Perindopril—coronary artery disease	9.57e-05	0.000527	CcSEcCtD
Solifenacin—Headache—Lovastatin—coronary artery disease	9.55e-05	0.000526	CcSEcCtD
Solifenacin—Pruritus—Valsartan—coronary artery disease	9.53e-05	0.000525	CcSEcCtD
Solifenacin—Dry mouth—Ramipril—coronary artery disease	9.53e-05	0.000525	CcSEcCtD
Solifenacin—Vomiting—Ezetimibe—coronary artery disease	9.51e-05	0.000524	CcSEcCtD
Solifenacin—Hypersensitivity—Pravastatin—coronary artery disease	9.5e-05	0.000523	CcSEcCtD
Solifenacin—Gastrointestinal pain—Perindopril—coronary artery disease	9.5e-05	0.000523	CcSEcCtD
Solifenacin—Angioedema—Lisinopril—coronary artery disease	9.48e-05	0.000522	CcSEcCtD
Solifenacin—Pruritus—Olmesartan—coronary artery disease	9.48e-05	0.000522	CcSEcCtD
Solifenacin—Decreased appetite—Losartan—coronary artery disease	9.47e-05	0.000521	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.46e-05	0.000521	CcSEcCtD
Solifenacin—Abdominal pain—Captopril—coronary artery disease	9.45e-05	0.000521	CcSEcCtD
Solifenacin—Dizziness—Simvastatin—coronary artery disease	9.43e-05	0.000519	CcSEcCtD
Solifenacin—Rash—Ezetimibe—coronary artery disease	9.43e-05	0.000519	CcSEcCtD
Solifenacin—Dermatitis—Ezetimibe—coronary artery disease	9.42e-05	0.000519	CcSEcCtD
Solifenacin—Confusional state—Ramipril—coronary artery disease	9.42e-05	0.000519	CcSEcCtD
Solifenacin—Asthenia—Niacin—coronary artery disease	9.39e-05	0.000517	CcSEcCtD
Solifenacin—Fatigue—Losartan—coronary artery disease	9.39e-05	0.000517	CcSEcCtD
Solifenacin—Headache—Ezetimibe—coronary artery disease	9.37e-05	0.000516	CcSEcCtD
Solifenacin—Anaphylactic shock—Ramipril—coronary artery disease	9.34e-05	0.000514	CcSEcCtD
Solifenacin—Dry mouth—Timolol—coronary artery disease	9.31e-05	0.000513	CcSEcCtD
Solifenacin—Constipation—Losartan—coronary artery disease	9.31e-05	0.000513	CcSEcCtD
Solifenacin—Vomiting—Eplerenone—coronary artery disease	9.31e-05	0.000512	CcSEcCtD
Solifenacin—Feeling abnormal—Furosemide—coronary artery disease	9.3e-05	0.000512	CcSEcCtD
Solifenacin—Nausea—Fenofibrate—coronary artery disease	9.27e-05	0.000511	CcSEcCtD
Solifenacin—Pruritus—Niacin—coronary artery disease	9.26e-05	0.00051	CcSEcCtD
Solifenacin—Asthenia—Pravastatin—coronary artery disease	9.25e-05	0.000509	CcSEcCtD
Solifenacin—Gastrointestinal pain—Furosemide—coronary artery disease	9.23e-05	0.000508	CcSEcCtD
Solifenacin—Rash—Eplerenone—coronary artery disease	9.23e-05	0.000508	CcSEcCtD
Solifenacin—Urticaria—Perindopril—coronary artery disease	9.22e-05	0.000508	CcSEcCtD
Solifenacin—Hypersensitivity—Trandolapril—coronary artery disease	9.22e-05	0.000508	CcSEcCtD
Solifenacin—Dermatitis—Eplerenone—coronary artery disease	9.22e-05	0.000508	CcSEcCtD
Solifenacin—Confusional state—Timolol—coronary artery disease	9.21e-05	0.000507	CcSEcCtD
Solifenacin—Hypersensitivity—Enalapril—coronary artery disease	9.19e-05	0.000506	CcSEcCtD
Solifenacin—Abdominal pain—Perindopril—coronary artery disease	9.18e-05	0.000505	CcSEcCtD
Solifenacin—Palpitations—Lisinopril—coronary artery disease	9.17e-05	0.000505	CcSEcCtD
Solifenacin—Headache—Eplerenone—coronary artery disease	9.17e-05	0.000505	CcSEcCtD
Solifenacin—Nervous system disorder—Ramipril—coronary artery disease	9.16e-05	0.000504	CcSEcCtD
Solifenacin—Anaphylactic shock—Timolol—coronary artery disease	9.13e-05	0.000503	CcSEcCtD
Solifenacin—Pruritus—Pravastatin—coronary artery disease	9.12e-05	0.000502	CcSEcCtD
Solifenacin—Nausea—Clopidogrel—coronary artery disease	9.12e-05	0.000502	CcSEcCtD
Solifenacin—Tachycardia—Ramipril—coronary artery disease	9.11e-05	0.000502	CcSEcCtD
Solifenacin—Skin disorder—Ramipril—coronary artery disease	9.07e-05	0.0005	CcSEcCtD
Solifenacin—Infection—Timolol—coronary artery disease	9.07e-05	0.000499	CcSEcCtD
Solifenacin—Vomiting—Simvastatin—coronary artery disease	9.07e-05	0.000499	CcSEcCtD
Solifenacin—Hypersensitivity—Telmisartan—coronary artery disease	9.06e-05	0.000499	CcSEcCtD
Solifenacin—Cough—Lisinopril—coronary artery disease	9.06e-05	0.000499	CcSEcCtD
Solifenacin—Nausea—Lovastatin—coronary artery disease	9.06e-05	0.000499	CcSEcCtD
Solifenacin—Rash—Simvastatin—coronary artery disease	8.99e-05	0.000495	CcSEcCtD
Solifenacin—Dermatitis—Simvastatin—coronary artery disease	8.98e-05	0.000495	CcSEcCtD
Solifenacin—Asthenia—Trandolapril—coronary artery disease	8.98e-05	0.000495	CcSEcCtD
Solifenacin—Feeling abnormal—Losartan—coronary artery disease	8.98e-05	0.000494	CcSEcCtD
Solifenacin—Urticaria—Furosemide—coronary artery disease	8.97e-05	0.000494	CcSEcCtD
Solifenacin—Nervous system disorder—Timolol—coronary artery disease	8.95e-05	0.000493	CcSEcCtD
Solifenacin—Asthenia—Enalapril—coronary artery disease	8.95e-05	0.000493	CcSEcCtD
Solifenacin—Headache—Simvastatin—coronary artery disease	8.93e-05	0.000492	CcSEcCtD
Solifenacin—Abdominal pain—Furosemide—coronary artery disease	8.92e-05	0.000491	CcSEcCtD
Solifenacin—Gastrointestinal pain—Losartan—coronary artery disease	8.91e-05	0.00049	CcSEcCtD
Solifenacin—Dizziness—Valsartan—coronary artery disease	8.91e-05	0.00049	CcSEcCtD
Solifenacin—Nausea—Ezetimibe—coronary artery disease	8.88e-05	0.000489	CcSEcCtD
Solifenacin—Skin disorder—Timolol—coronary artery disease	8.87e-05	0.000488	CcSEcCtD
Solifenacin—Dizziness—Olmesartan—coronary artery disease	8.86e-05	0.000488	CcSEcCtD
Solifenacin—Pruritus—Trandolapril—coronary artery disease	8.86e-05	0.000488	CcSEcCtD
Solifenacin—Asthenia—Telmisartan—coronary artery disease	8.82e-05	0.000486	CcSEcCtD
Solifenacin—Pruritus—Enalapril—coronary artery disease	8.82e-05	0.000486	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	8.77e-05	0.000483	CcSEcCtD
Solifenacin—Pruritus—Telmisartan—coronary artery disease	8.7e-05	0.000479	CcSEcCtD
Solifenacin—Nausea—Eplerenone—coronary artery disease	8.69e-05	0.000479	CcSEcCtD
Solifenacin—Dizziness—Niacin—coronary artery disease	8.66e-05	0.000477	CcSEcCtD
Solifenacin—Urticaria—Losartan—coronary artery disease	8.65e-05	0.000476	CcSEcCtD
Solifenacin—Dry mouth—Lisinopril—coronary artery disease	8.64e-05	0.000476	CcSEcCtD
Solifenacin—Abdominal pain—Losartan—coronary artery disease	8.61e-05	0.000474	CcSEcCtD
Solifenacin—Asthenia—Captopril—coronary artery disease	8.58e-05	0.000473	CcSEcCtD
Solifenacin—Vomiting—Valsartan—coronary artery disease	8.56e-05	0.000471	CcSEcCtD
Solifenacin—Confusional state—Lisinopril—coronary artery disease	8.54e-05	0.00047	CcSEcCtD
Solifenacin—Dizziness—Pravastatin—coronary artery disease	8.53e-05	0.000469	CcSEcCtD
Solifenacin—Vomiting—Olmesartan—coronary artery disease	8.52e-05	0.000469	CcSEcCtD
Solifenacin—Rash—Valsartan—coronary artery disease	8.49e-05	0.000468	CcSEcCtD
Solifenacin—Dermatitis—Valsartan—coronary artery disease	8.48e-05	0.000467	CcSEcCtD
Solifenacin—Nausea—Simvastatin—coronary artery disease	8.47e-05	0.000466	CcSEcCtD
Solifenacin—Anaphylactic shock—Lisinopril—coronary artery disease	8.47e-05	0.000466	CcSEcCtD
Solifenacin—Pruritus—Captopril—coronary artery disease	8.46e-05	0.000466	CcSEcCtD
Solifenacin—Rash—Olmesartan—coronary artery disease	8.45e-05	0.000465	CcSEcCtD
Solifenacin—Dermatitis—Olmesartan—coronary artery disease	8.44e-05	0.000465	CcSEcCtD
Solifenacin—Headache—Valsartan—coronary artery disease	8.44e-05	0.000465	CcSEcCtD
Solifenacin—Infection—Lisinopril—coronary artery disease	8.41e-05	0.000463	CcSEcCtD
Solifenacin—Headache—Olmesartan—coronary artery disease	8.4e-05	0.000462	CcSEcCtD
Solifenacin—Asthenia—Perindopril—coronary artery disease	8.33e-05	0.000459	CcSEcCtD
Solifenacin—Vomiting—Niacin—coronary artery disease	8.33e-05	0.000458	CcSEcCtD
Solifenacin—Hypersensitivity—Furosemide—coronary artery disease	8.32e-05	0.000458	CcSEcCtD
Solifenacin—Somnolence—Ramipril—coronary artery disease	8.3e-05	0.000457	CcSEcCtD
Solifenacin—Dizziness—Trandolapril—coronary artery disease	8.28e-05	0.000456	CcSEcCtD
Solifenacin—Tachycardia—Lisinopril—coronary artery disease	8.27e-05	0.000455	CcSEcCtD
Solifenacin—Rash—Niacin—coronary artery disease	8.26e-05	0.000455	CcSEcCtD
Solifenacin—Dermatitis—Niacin—coronary artery disease	8.25e-05	0.000454	CcSEcCtD
Solifenacin—Dizziness—Enalapril—coronary artery disease	8.25e-05	0.000454	CcSEcCtD
Solifenacin—Skin disorder—Lisinopril—coronary artery disease	8.23e-05	0.000453	CcSEcCtD
Solifenacin—Dyspepsia—Ramipril—coronary artery disease	8.22e-05	0.000453	CcSEcCtD
Solifenacin—Pruritus—Perindopril—coronary artery disease	8.22e-05	0.000452	CcSEcCtD
Solifenacin—Headache—Niacin—coronary artery disease	8.2e-05	0.000452	CcSEcCtD
Solifenacin—Vomiting—Pravastatin—coronary artery disease	8.2e-05	0.000451	CcSEcCtD
Solifenacin—Dizziness—Telmisartan—coronary artery disease	8.13e-05	0.000448	CcSEcCtD
Solifenacin—Rash—Pravastatin—coronary artery disease	8.13e-05	0.000448	CcSEcCtD
Solifenacin—Dermatitis—Pravastatin—coronary artery disease	8.12e-05	0.000447	CcSEcCtD
Solifenacin—Decreased appetite—Ramipril—coronary artery disease	8.12e-05	0.000447	CcSEcCtD
Solifenacin—Somnolence—Timolol—coronary artery disease	8.12e-05	0.000447	CcSEcCtD
Solifenacin—Asthenia—Furosemide—coronary artery disease	8.1e-05	0.000446	CcSEcCtD
Solifenacin—Headache—Pravastatin—coronary artery disease	8.08e-05	0.000445	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Ramipril—coronary artery disease	8.06e-05	0.000444	CcSEcCtD
Solifenacin—Fatigue—Ramipril—coronary artery disease	8.05e-05	0.000443	CcSEcCtD
Solifenacin—Dyspepsia—Timolol—coronary artery disease	8.04e-05	0.000443	CcSEcCtD
Solifenacin—Hypersensitivity—Losartan—coronary artery disease	8.02e-05	0.000442	CcSEcCtD
Solifenacin—Nausea—Valsartan—coronary artery disease	8e-05	0.00044	CcSEcCtD
Solifenacin—Pruritus—Furosemide—coronary artery disease	7.99e-05	0.00044	CcSEcCtD
Solifenacin—Constipation—Ramipril—coronary artery disease	7.99e-05	0.00044	CcSEcCtD
Solifenacin—Nausea—Olmesartan—coronary artery disease	7.96e-05	0.000438	CcSEcCtD
Solifenacin—Vomiting—Trandolapril—coronary artery disease	7.96e-05	0.000438	CcSEcCtD
Solifenacin—Decreased appetite—Timolol—coronary artery disease	7.94e-05	0.000437	CcSEcCtD
Solifenacin—Vomiting—Enalapril—coronary artery disease	7.93e-05	0.000437	CcSEcCtD
Solifenacin—Dizziness—Captopril—coronary artery disease	7.91e-05	0.000435	CcSEcCtD
Solifenacin—Rash—Trandolapril—coronary artery disease	7.89e-05	0.000435	CcSEcCtD
Solifenacin—Dermatitis—Trandolapril—coronary artery disease	7.89e-05	0.000434	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Timolol—coronary artery disease	7.88e-05	0.000434	CcSEcCtD
Solifenacin—Fatigue—Timolol—coronary artery disease	7.87e-05	0.000433	CcSEcCtD
Solifenacin—Rash—Enalapril—coronary artery disease	7.86e-05	0.000433	CcSEcCtD
Solifenacin—Dermatitis—Enalapril—coronary artery disease	7.85e-05	0.000433	CcSEcCtD
Solifenacin—Headache—Trandolapril—coronary artery disease	7.84e-05	0.000432	CcSEcCtD
Solifenacin—Vomiting—Telmisartan—coronary artery disease	7.82e-05	0.000431	CcSEcCtD
Solifenacin—Asthenia—Losartan—coronary artery disease	7.81e-05	0.00043	CcSEcCtD
Solifenacin—Headache—Enalapril—coronary artery disease	7.81e-05	0.00043	CcSEcCtD
Solifenacin—Nausea—Niacin—coronary artery disease	7.78e-05	0.000428	CcSEcCtD
Solifenacin—Rash—Telmisartan—coronary artery disease	7.75e-05	0.000427	CcSEcCtD
Solifenacin—Dermatitis—Telmisartan—coronary artery disease	7.75e-05	0.000427	CcSEcCtD
Solifenacin—Pruritus—Losartan—coronary artery disease	7.71e-05	0.000424	CcSEcCtD
Solifenacin—Headache—Telmisartan—coronary artery disease	7.7e-05	0.000424	CcSEcCtD
Solifenacin—Feeling abnormal—Ramipril—coronary artery disease	7.7e-05	0.000424	CcSEcCtD
Solifenacin—Dizziness—Perindopril—coronary artery disease	7.68e-05	0.000423	CcSEcCtD
Solifenacin—Nausea—Pravastatin—coronary artery disease	7.66e-05	0.000422	CcSEcCtD
Solifenacin—Gastrointestinal pain—Ramipril—coronary artery disease	7.64e-05	0.000421	CcSEcCtD
Solifenacin—Vomiting—Captopril—coronary artery disease	7.6e-05	0.000419	CcSEcCtD
Solifenacin—Rash—Captopril—coronary artery disease	7.54e-05	0.000415	CcSEcCtD
Solifenacin—Dermatitis—Captopril—coronary artery disease	7.53e-05	0.000415	CcSEcCtD
Solifenacin—Somnolence—Lisinopril—coronary artery disease	7.53e-05	0.000415	CcSEcCtD
Solifenacin—Feeling abnormal—Timolol—coronary artery disease	7.52e-05	0.000414	CcSEcCtD
Solifenacin—Headache—Captopril—coronary artery disease	7.49e-05	0.000413	CcSEcCtD
Solifenacin—Gastrointestinal pain—Timolol—coronary artery disease	7.47e-05	0.000411	CcSEcCtD
Solifenacin—Dizziness—Furosemide—coronary artery disease	7.46e-05	0.000411	CcSEcCtD
Solifenacin—Dyspepsia—Lisinopril—coronary artery disease	7.46e-05	0.000411	CcSEcCtD
Solifenacin—Nausea—Trandolapril—coronary artery disease	7.44e-05	0.000409	CcSEcCtD
Solifenacin—Urticaria—Ramipril—coronary artery disease	7.42e-05	0.000409	CcSEcCtD
Solifenacin—Nausea—Enalapril—coronary artery disease	7.41e-05	0.000408	CcSEcCtD
Solifenacin—Vomiting—Perindopril—coronary artery disease	7.38e-05	0.000407	CcSEcCtD
Solifenacin—Abdominal pain—Ramipril—coronary artery disease	7.38e-05	0.000407	CcSEcCtD
Solifenacin—Decreased appetite—Lisinopril—coronary artery disease	7.36e-05	0.000405	CcSEcCtD
Solifenacin—Rash—Perindopril—coronary artery disease	7.32e-05	0.000403	CcSEcCtD
Solifenacin—Dermatitis—Perindopril—coronary artery disease	7.31e-05	0.000403	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.31e-05	0.000403	CcSEcCtD
Solifenacin—Nausea—Telmisartan—coronary artery disease	7.31e-05	0.000402	CcSEcCtD
Solifenacin—Fatigue—Lisinopril—coronary artery disease	7.3e-05	0.000402	CcSEcCtD
Solifenacin—Headache—Perindopril—coronary artery disease	7.27e-05	0.000401	CcSEcCtD
Solifenacin—Urticaria—Timolol—coronary artery disease	7.25e-05	0.000399	CcSEcCtD
Solifenacin—Constipation—Lisinopril—coronary artery disease	7.24e-05	0.000399	CcSEcCtD
Solifenacin—Abdominal pain—Timolol—coronary artery disease	7.22e-05	0.000397	CcSEcCtD
Solifenacin—Dizziness—Losartan—coronary artery disease	7.2e-05	0.000397	CcSEcCtD
Solifenacin—Vomiting—Furosemide—coronary artery disease	7.18e-05	0.000395	CcSEcCtD
Solifenacin—Rash—Furosemide—coronary artery disease	7.12e-05	0.000392	CcSEcCtD
Solifenacin—Dermatitis—Furosemide—coronary artery disease	7.11e-05	0.000392	CcSEcCtD
Solifenacin—Nausea—Captopril—coronary artery disease	7.1e-05	0.000391	CcSEcCtD
Solifenacin—Headache—Furosemide—coronary artery disease	7.07e-05	0.000389	CcSEcCtD
Solifenacin—Feeling abnormal—Lisinopril—coronary artery disease	6.98e-05	0.000384	CcSEcCtD
Solifenacin—Gastrointestinal pain—Lisinopril—coronary artery disease	6.93e-05	0.000381	CcSEcCtD
Solifenacin—Vomiting—Losartan—coronary artery disease	6.92e-05	0.000381	CcSEcCtD
Solifenacin—Nausea—Perindopril—coronary artery disease	6.9e-05	0.00038	CcSEcCtD
Solifenacin—Hypersensitivity—Ramipril—coronary artery disease	6.88e-05	0.000379	CcSEcCtD
Solifenacin—Rash—Losartan—coronary artery disease	6.87e-05	0.000378	CcSEcCtD
Solifenacin—Dermatitis—Losartan—coronary artery disease	6.86e-05	0.000378	CcSEcCtD
Solifenacin—Headache—Losartan—coronary artery disease	6.82e-05	0.000376	CcSEcCtD
Solifenacin—Urticaria—Lisinopril—coronary artery disease	6.73e-05	0.000371	CcSEcCtD
Solifenacin—Hypersensitivity—Timolol—coronary artery disease	6.73e-05	0.00037	CcSEcCtD
Solifenacin—Nausea—Furosemide—coronary artery disease	6.7e-05	0.000369	CcSEcCtD
Solifenacin—Asthenia—Ramipril—coronary artery disease	6.7e-05	0.000369	CcSEcCtD
Solifenacin—Abdominal pain—Lisinopril—coronary artery disease	6.7e-05	0.000369	CcSEcCtD
Solifenacin—Pruritus—Ramipril—coronary artery disease	6.61e-05	0.000364	CcSEcCtD
Solifenacin—Asthenia—Timolol—coronary artery disease	6.55e-05	0.000361	CcSEcCtD
Solifenacin—Nausea—Losartan—coronary artery disease	6.47e-05	0.000356	CcSEcCtD
Solifenacin—Pruritus—Timolol—coronary artery disease	6.46e-05	0.000356	CcSEcCtD
Solifenacin—Hypersensitivity—Lisinopril—coronary artery disease	6.24e-05	0.000344	CcSEcCtD
Solifenacin—Dizziness—Ramipril—coronary artery disease	6.18e-05	0.00034	CcSEcCtD
Solifenacin—Asthenia—Lisinopril—coronary artery disease	6.08e-05	0.000335	CcSEcCtD
Solifenacin—Dizziness—Timolol—coronary artery disease	6.04e-05	0.000332	CcSEcCtD
Solifenacin—Pruritus—Lisinopril—coronary artery disease	5.99e-05	0.00033	CcSEcCtD
Solifenacin—Vomiting—Ramipril—coronary artery disease	5.94e-05	0.000327	CcSEcCtD
Solifenacin—Rash—Ramipril—coronary artery disease	5.89e-05	0.000324	CcSEcCtD
Solifenacin—Dermatitis—Ramipril—coronary artery disease	5.88e-05	0.000324	CcSEcCtD
Solifenacin—Headache—Ramipril—coronary artery disease	5.85e-05	0.000322	CcSEcCtD
Solifenacin—Vomiting—Timolol—coronary artery disease	5.8e-05	0.00032	CcSEcCtD
Solifenacin—Rash—Timolol—coronary artery disease	5.76e-05	0.000317	CcSEcCtD
Solifenacin—Dermatitis—Timolol—coronary artery disease	5.75e-05	0.000317	CcSEcCtD
Solifenacin—Headache—Timolol—coronary artery disease	5.72e-05	0.000315	CcSEcCtD
Solifenacin—Dizziness—Lisinopril—coronary artery disease	5.6e-05	0.000308	CcSEcCtD
Solifenacin—Nausea—Ramipril—coronary artery disease	5.55e-05	0.000305	CcSEcCtD
Solifenacin—Nausea—Timolol—coronary artery disease	5.42e-05	0.000299	CcSEcCtD
Solifenacin—Vomiting—Lisinopril—coronary artery disease	5.39e-05	0.000297	CcSEcCtD
Solifenacin—Rash—Lisinopril—coronary artery disease	5.34e-05	0.000294	CcSEcCtD
Solifenacin—Dermatitis—Lisinopril—coronary artery disease	5.34e-05	0.000294	CcSEcCtD
Solifenacin—Headache—Lisinopril—coronary artery disease	5.31e-05	0.000292	CcSEcCtD
Solifenacin—Nausea—Lisinopril—coronary artery disease	5.03e-05	0.000277	CcSEcCtD
Solifenacin—CHRM5—Signaling Pathways—IL6R—coronary artery disease	5.03e-06	5.52e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LPL—coronary artery disease	5.03e-06	5.52e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GPX4—coronary artery disease	5.02e-06	5.51e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HK1—coronary artery disease	5.02e-06	5.51e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SULT1A1—coronary artery disease	5.02e-06	5.51e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCG5—coronary artery disease	5.02e-06	5.51e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CSF2—coronary artery disease	5.02e-06	5.51e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGF1—coronary artery disease	5.02e-06	5.51e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	5e-06	5.49e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	5e-06	5.49e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	4.99e-06	5.47e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	4.99e-06	5.47e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—APOA1—coronary artery disease	4.99e-06	5.47e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LPL—coronary artery disease	4.98e-06	5.47e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IGF1—coronary artery disease	4.96e-06	5.45e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HADHA—coronary artery disease	4.96e-06	5.45e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—MAPK1—coronary artery disease	4.94e-06	5.42e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	4.94e-06	5.42e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	4.94e-06	5.42e-05	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—PIK3CA—coronary artery disease	4.93e-06	5.41e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SERPINE1—coronary artery disease	4.92e-06	5.4e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.91e-06	5.38e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	4.87e-06	5.35e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	4.86e-06	5.33e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—LPA—coronary artery disease	4.85e-06	5.32e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	4.81e-06	5.28e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—FGF2—coronary artery disease	4.77e-06	5.23e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	4.76e-06	5.22e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	4.74e-06	5.2e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	4.74e-06	5.2e-05	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—PIK3CA—coronary artery disease	4.72e-06	5.18e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	4.72e-06	5.18e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SERPINE1—coronary artery disease	4.71e-06	5.17e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NOS3—coronary artery disease	4.7e-06	5.16e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PLCB3—coronary artery disease	4.7e-06	5.16e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	4.7e-06	5.15e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	4.67e-06	5.13e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOA5—coronary artery disease	4.65e-06	5.1e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	4.65e-06	5.1e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	4.64e-06	5.09e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	4.59e-06	5.04e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—JAK2—coronary artery disease	4.57e-06	5.01e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—FGF2—coronary artery disease	4.56e-06	5.01e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—P4HB—coronary artery disease	4.56e-06	5e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	4.55e-06	4.99e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—C3—coronary artery disease	4.54e-06	4.99e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	4.54e-06	4.98e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—C3—coronary artery disease	4.53e-06	4.97e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NOS3—coronary artery disease	4.5e-06	4.94e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	4.49e-06	4.93e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—C3—coronary artery disease	4.49e-06	4.92e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	4.48e-06	4.91e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—PIK3CA—coronary artery disease	4.48e-06	4.91e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARG—coronary artery disease	4.39e-06	4.82e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—JAK2—coronary artery disease	4.37e-06	4.8e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	4.33e-06	4.75e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—POMC—coronary artery disease	4.33e-06	4.75e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	4.32e-06	4.74e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AGT—coronary artery disease	4.32e-06	4.74e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AGT—coronary artery disease	4.3e-06	4.72e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—PIK3CA—coronary artery disease	4.29e-06	4.7e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	4.28e-06	4.69e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AGT—coronary artery disease	4.26e-06	4.68e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOE—coronary artery disease	4.23e-06	4.64e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—LEP—coronary artery disease	4.23e-06	4.64e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—VCAN—coronary artery disease	4.22e-06	4.63e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—LEP—coronary artery disease	4.22e-06	4.63e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOE—coronary artery disease	4.22e-06	4.63e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALDOA—coronary artery disease	4.19e-06	4.59e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APOA1—coronary artery disease	4.18e-06	4.59e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—LEP—coronary artery disease	4.18e-06	4.58e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOE—coronary artery disease	4.18e-06	4.58e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CXCL8—coronary artery disease	4.17e-06	4.57e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APOA1—coronary artery disease	4.17e-06	4.57e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KDR—coronary artery disease	4.14e-06	4.55e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KDR—coronary artery disease	4.13e-06	4.53e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APOA1—coronary artery disease	4.13e-06	4.53e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	4.12e-06	4.52e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	4.1e-06	4.5e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KDR—coronary artery disease	4.09e-06	4.49e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—DCN—coronary artery disease	4.07e-06	4.46e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	4.06e-06	4.46e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ESR1—coronary artery disease	4.04e-06	4.43e-05	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—AKT1—coronary artery disease	4.03e-06	4.42e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ESR1—coronary artery disease	4.03e-06	4.42e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CXCL8—coronary artery disease	3.99e-06	4.38e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CASP3—coronary artery disease	3.99e-06	4.38e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—F2—coronary artery disease	3.99e-06	4.38e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FN1—coronary artery disease	3.99e-06	4.38e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ESR1—coronary artery disease	3.99e-06	4.37e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—F2—coronary artery disease	3.98e-06	4.36e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FN1—coronary artery disease	3.98e-06	4.36e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	3.97e-06	4.36e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—coronary artery disease	3.96e-06	4.35e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	3.96e-06	4.35e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.95e-06	4.34e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALB—coronary artery disease	3.95e-06	4.33e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	3.94e-06	4.33e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—F2—coronary artery disease	3.94e-06	4.32e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FN1—coronary artery disease	3.94e-06	4.32e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	3.93e-06	4.31e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	3.92e-06	4.3e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	3.89e-06	4.27e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCND1—coronary artery disease	3.88e-06	4.26e-05	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—AKT1—coronary artery disease	3.86e-06	4.23e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.85e-06	4.23e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—LIPC—coronary artery disease	3.85e-06	4.23e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.85e-06	4.23e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HBA1—coronary artery disease	3.85e-06	4.23e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOC3—coronary artery disease	3.83e-06	4.2e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CASP3—coronary artery disease	3.82e-06	4.19e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KIT—coronary artery disease	3.82e-06	4.19e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—LDLR—coronary artery disease	3.81e-06	4.18e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KIT—coronary artery disease	3.81e-06	4.18e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—coronary artery disease	3.8e-06	4.17e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—NOS3—coronary artery disease	3.78e-06	4.15e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—coronary artery disease	3.77e-06	4.14e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KIT—coronary artery disease	3.77e-06	4.14e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.76e-06	4.13e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.76e-06	4.13e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCND1—coronary artery disease	3.72e-06	4.08e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GCLC—coronary artery disease	3.72e-06	4.08e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CETP—coronary artery disease	3.72e-06	4.08e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—SDC1—coronary artery disease	3.68e-06	4.03e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	3.66e-06	4.02e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—AKT1—coronary artery disease	3.66e-06	4.01e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	3.65e-06	4.01e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—POMC—coronary artery disease	3.63e-06	3.99e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CREB1—coronary artery disease	3.63e-06	3.99e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—POMC—coronary artery disease	3.62e-06	3.97e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CREB1—coronary artery disease	3.62e-06	3.97e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	3.62e-06	3.97e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—coronary artery disease	3.61e-06	3.96e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—POMC—coronary artery disease	3.59e-06	3.94e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CREB1—coronary artery disease	3.59e-06	3.94e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCL2—coronary artery disease	3.56e-06	3.9e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6R—coronary artery disease	3.54e-06	3.89e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCL2—coronary artery disease	3.54e-06	3.89e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6R—coronary artery disease	3.53e-06	3.88e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCL2—coronary artery disease	3.51e-06	3.85e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	3.5e-06	3.84e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6R—coronary artery disease	3.5e-06	3.84e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF1—coronary artery disease	3.5e-06	3.84e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF1—coronary artery disease	3.48e-06	3.82e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	3.48e-06	3.82e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PSMB5—coronary artery disease	3.47e-06	3.81e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PSMA6—coronary artery disease	3.47e-06	3.81e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	3.47e-06	3.8e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PTGS2—coronary artery disease	3.46e-06	3.79e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF1—coronary artery disease	3.45e-06	3.79e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	3.43e-06	3.77e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CTGF—coronary artery disease	3.39e-06	3.72e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—coronary artery disease	3.39e-06	3.72e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HMGCR—coronary artery disease	3.36e-06	3.69e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT2—coronary artery disease	3.36e-06	3.69e-05	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.32e-06	3.65e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	3.32e-06	3.64e-05	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	3.31e-06	3.64e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	3.31e-06	3.63e-05	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	3.28e-06	3.6e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	3.28e-06	3.6e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	3.24e-06	3.56e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—FGF2—coronary artery disease	3.21e-06	3.53e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—FGF2—coronary artery disease	3.2e-06	3.51e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—FGF2—coronary artery disease	3.17e-06	3.48e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NOS3—coronary artery disease	3.17e-06	3.48e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NOS3—coronary artery disease	3.16e-06	3.47e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NOS3—coronary artery disease	3.13e-06	3.43e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	3.11e-06	3.41e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.09e-06	3.39e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—JAK2—coronary artery disease	3.08e-06	3.38e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—JAK2—coronary artery disease	3.07e-06	3.37e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	3.05e-06	3.34e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—JAK2—coronary artery disease	3.04e-06	3.34e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	3.02e-06	3.31e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	3.01e-06	3.3e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ABCA1—coronary artery disease	3e-06	3.29e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	2.98e-06	3.27e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	2.98e-06	3.27e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	2.92e-06	3.2e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT1—coronary artery disease	2.9e-06	3.18e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GGT1—coronary artery disease	2.9e-06	3.18e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	2.81e-06	3.08e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	2.8e-06	3.07e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	2.78e-06	3.04e-05	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.72e-06	2.98e-05	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	2.71e-06	2.97e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CASP3—coronary artery disease	2.69e-06	2.95e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CASP3—coronary artery disease	2.68e-06	2.94e-05	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	2.68e-06	2.94e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—coronary artery disease	2.67e-06	2.93e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—coronary artery disease	2.66e-06	2.92e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CASP3—coronary artery disease	2.66e-06	2.91e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	2.64e-06	2.9e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—coronary artery disease	2.64e-06	2.9e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCND1—coronary artery disease	2.62e-06	2.87e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCND1—coronary artery disease	2.61e-06	2.86e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.61e-06	2.86e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCND1—coronary artery disease	2.59e-06	2.84e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.58e-06	2.83e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.57e-06	2.82e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—coronary artery disease	2.54e-06	2.79e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CAT—coronary artery disease	2.54e-06	2.78e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—coronary artery disease	2.53e-06	2.78e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	2.53e-06	2.78e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—coronary artery disease	2.51e-06	2.75e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	2.47e-06	2.71e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOB—coronary artery disease	2.46e-06	2.7e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	2.46e-06	2.7e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	2.43e-06	2.67e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTM1—coronary artery disease	2.4e-06	2.63e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—LPL—coronary artery disease	2.35e-06	2.58e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—coronary artery disease	2.34e-06	2.57e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GPX1—coronary artery disease	2.29e-06	2.52e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	2.28e-06	2.51e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	2.28e-06	2.5e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	2.25e-06	2.47e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—coronary artery disease	2.24e-06	2.46e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CD36—coronary artery disease	2.23e-06	2.45e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.21e-06	2.42e-05	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AKT1—coronary artery disease	2.16e-06	2.37e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CA—coronary artery disease	2.13e-06	2.33e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.12e-06	2.32e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	2.1e-06	2.3e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	2.09e-06	2.29e-05	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AKT1—coronary artery disease	2.07e-06	2.27e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	2.07e-06	2.27e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	2.06e-06	2.25e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	2.05e-06	2.25e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	2.03e-06	2.23e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AGT—coronary artery disease	2.01e-06	2.21e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOE—coronary artery disease	1.97e-06	2.16e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—APOA1—coronary artery disease	1.95e-06	2.14e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.78e-06	1.96e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	1.78e-06	1.95e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.76e-06	1.93e-05	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—AKT1—coronary artery disease	1.74e-06	1.91e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARG—coronary artery disease	1.72e-06	1.88e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—POMC—coronary artery disease	1.69e-06	1.86e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.58e-06	1.73e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—coronary artery disease	1.57e-06	1.73e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.56e-06	1.71e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALB—coronary artery disease	1.54e-06	1.69e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NOS3—coronary artery disease	1.48e-06	1.62e-05	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.46e-06	1.6e-05	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKT1—coronary artery disease	1.45e-06	1.59e-05	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKT1—coronary artery disease	1.44e-06	1.58e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.35e-06	1.48e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	8.31e-07	9.12e-06	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKT1—coronary artery disease	6.79e-07	7.45e-06	CbGpPWpGaD
